COMMUNIQUÉS West-GlobeNewswire

The following is a statement from Comprehensive Pharmacy Services on the death of Dayna Less

21/11/2018 - 15:00

MEMPHIS, Tenn., Nov. 21, 2018 (GLOBE NEWSWIRE) -- On Monday, November 19, 2018, a gunman entered Mercy Hospital & Medical Center in Chicago, killing a police officer, a doctor and a pharmacy resident, Dayna Less, [...]

Weekend Unlimited Establishes Retail Presence in Canada -- CFN Media

21/11/2018 - 15:00

SEATTLE, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Ceapro Inc. Reports 2018 Third Quarter and Nine-Month Financial Results and Operational Highlights

21/11/2018 - 15:00

EDMONTON, Alberta, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. ( TSX-V: CZO) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients [...]

International Cannabis Corp. Building Global Network -- CFN Media

21/11/2018 - 15:00

SEATTLE, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Minerva Neurosciences to Present at Evercore ISI HealthCONx Conference on November 28, 2018

21/11/2018 - 14:30

WALTHAM, Mass., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system [...]

Supreme Cannabis Focused on Disciplined Deployment of Capital -- CFN Media

21/11/2018 - 14:30

SEATTLE, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Halo Labs: Improving Investor Reach, Transparency, and Liquidity -- CFN Media

21/11/2018 - 14:30

SEATTLE, Wash., Nov. 21, 2018 (GLOBE NEWSWIRE) -- -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]

Align Technology to Speak at Upcoming Financial Conferences

21/11/2018 - 14:30

SAN JOSE, Calif., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will [...]

BLOCKStrain Brings Security, Scalability, and Transparency to Cannabis Supply Chain, Plus Exclusive Executive Interview -- CFN Media

21/11/2018 - 14:30

SEATTLE, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

PhaseBio To Report Third Quarter 2018 Financial and Business Results on November 29, 2018

21/11/2018 - 14:00

MALVERN, Pa. and SAN DIEGO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]

VBL Therapeutics to Present at the Piper Jaffray 30th Annual Healthcare Conference on November 28

21/11/2018 - 14:00

TEL AVIV, Israel, Nov. 21, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Abattis Retains Canadian and American Compliance Agency and Provides Company Update

21/11/2018 - 14:00

VANCOUVER, British Columbia, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the appointment of Ingredient Identity LLC (“ [...]

BioSyent Releases Results for Third Quarter and First Nine Months of 2018

21/11/2018 - 14:00

TORONTO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its financial results for the three and nine months ended September 30, 2018. Key highlights include: [...]

Nexstim Plc's resolutions of the Extraordinary General Meeting of Shareholders

21/11/2018 - 13:01

Company announcement, Helsinki, 21 November 2018 at 2:00 PM Nexstim Plc's resolutions of the Extraordinary General Meeting of Shareholders Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company [...]

CureVac to Present at the 19th Annual Piper Jaffray Healthcare Conference

21/11/2018 - 13:00

TÜBINGEN, Germany and BOSTON, Nov. 21, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichella, Chief Executive [...]

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

21/11/2018 - 13:00

ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 21, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, [...]

Aleafia and Serruya Private Equity Reach Agreement for National Retail Dispensary, top Performing Brands and $10M Investment

21/11/2018 - 13:00

Transactions Positions Aleafia as Major Supplier, Retailer of Adult-use Cannabis TORONTO, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“ or the “Company“), and [...]

Clementia to Present at the Evercore ISI HealthCONx Conference

21/11/2018 - 12:30

MONTREAL, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders and other diseases, [...]

Clementia annonce qu’elle participera à la Conférence Evercore ISI HealthCONx (« Evercore ISI HealthCONx Conference »)

21/11/2018 - 12:30

MONTRÉAL, 21 nov. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc . (Nasdaq: CMTA), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]